Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK®)

Madeleine Duvic*, Timothy M. Kuzel, Elise A. Olsen, Ann G. Martin, Francine M. Foss, Youn H. Kim, Peter W. Heald, Patricia Bacha, Jean Nichols, Astra Liepa

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Fingerprint

Dive into the research topics of 'Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK®)'. Together they form a unique fingerprint.

Medicine & Life Sciences